Tomorrow Capital
Overview
Tomorrow Capital is a US$ 100 million early-stage investment fund that partners with entrepreneurs to build the next generation of consumer brands in India. It provides long-term patient capital and hands-on support. The firm focuses on early-stage companies in the consumer brands sector.
Portfolio Companies
7
Website
tomorrowcap.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leverage Edu | Mar 2022 | Series B | Co-investor |
| Fina Labs, Inc. | Aug 2026 | Seed | Lead |
| Zeno Health | Sep 2019 | Series A Extension | Co-investor |
| Robbin | May 2026 | Seed | Co-investor |
| Workcell Solutions Private Limited | Sep 2019 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Tomorrow Capital based?
Tomorrow Capital is headquartered in Mumbai, Maharashtra, India.
When was Tomorrow Capital founded?
Founding year information for Tomorrow Capital is not publicly available.
How many portfolio companies does Tomorrow Capital have?
Tomorrow Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Tomorrow Capital's portfolio?
Portfolio companies visible on Caplight include Leverage Edu, Fina Labs, Inc., Zeno Health, Robbin, Workcell Solutions Private Limited.
What was Tomorrow Capital's most recent investment shown here?
Tomorrow Capital's most recent investment in this portfolio sample was in Fina Labs, Inc. in 2026.
What sectors does Tomorrow Capital focus on?
Tomorrow Capital focuses on FinTech, Healthcare & Life Sciences, FinTech, FinTech, Consumer & Commerce, Healthcare & Life Sciences, FinTech, Enterprise Software, Consumer & Commerce, FinTech, Enterprise Software, Enterprise Software, Enterprise Software, Consumer & Commerce.
What company stages does Tomorrow Capital focus on?
Tomorrow Capital typically invests at the Early stage.
What is Tomorrow Capital's AUM?
Tomorrow Capital's assets under management are estimated between $100.0M and $100.0M.